References
1. M K. Pandey, T. R. DeGrado. Glycogen Synthase Kinase -3 (GSK-3) Targeted Therapy and Imaging. Theranostics, 2016:6(4):571-593.
2. G. Luo, L. Chen, C. R. Burton, H. Xiao, P. Sivaprakasam et. al. Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors. J Med Chem. 2016:59(3):1041-1051.